上海金畔生物科技有限公司是Detroit品牌代理商 ，欢迎访问官网了解更多产品信息和订购。
Detroit
简要描述：
Detroit R＆D，Inc.成立于1997年，由Hyesook Kim博士创立，致力于提供最高质量的产品，专于研究环境健康科学，高血压和乳腺癌和前列腺癌领域.
Detroit R＆D，Inc.成立于1997年，由Hyesook Kim博士创立，致力于提供最高质量的产品，专于研究环境健康科学，高血压和乳腺癌和前列腺癌领域，包括：生物活性类花生酸，环境雌激素，氧化应激，DNA损伤，非洲爪蟾，药物代谢，糖基化c-myc和p53，乳腺和前列腺微阵列和伤口愈合。
Detroit R&D, Inc. was founded in 1997 by Dr. Hyesook Kim as a company dedicated to building a relationship of trust with the research community, by providing the highest quality products through leading-edge technology. Detroit R&D specializes in Environmental Health Sciences, Hypertension and Breast and Prostate Cancers including:
• Research on biologically active eicosanoids such as EET, DHET, 20-HETE and 8-isoprostane, environmental estrogens such as BPA, prostaglandin H synthase (PGHS, also called COX), cytochromes P450 (CYPs), glutathione S-transferases (GSTs), oxidative stress, DNA damage, Xenopus, drug-metabolism, glycosylated c-myc and p53, breast and prostate microarrays and wound healing.
• Novel hypertension (US patents) and breast cancer (patent pending) drug screening kits.
• Anti-breast cancer drug candidates (patent pending).
Detroit R&D has established a track record of success:
· Sales of products to Belgium, Japan, Germany, Australia, Italy, Hong Kong, Thailand, Czech Republic, China, USA, Canada, South Korea, United Kingdom, Brazil, Spain, Kuwait, and Taiwan by direct sales and via distributors.
· We have funding for 17 National Institutes of Health (NIH) SBIR Phase I and II projects (>8.5 million), including hypertension diagnosis, mitochondrial DNA damage and cancer microarray projects.
Pending grants: SBIR Phase II (PI, glycosylated proteins in breast cancer), R21 (PI, prostate cancer cachexia) and Norway Prostate Cancer grant (Co-I, Glycosylated proteins in prostate cancer). > Detroit R&D holds 7 issued and 6 pending patents.
产品列表：
|
Detroit R&D
|
DH1
|
(1-Kit) 14,15-DHET Hypertension ELISA Kit
|
|
Detroit R&D
|
DH11
|
(2-Kit) 14,15-DHET Hypertension ELISA Kit
|
|
Detroit R&D
|
DH21
|
(5-Kit) 14,15-DHET Hypertension ELISA Kit
|
|
Detroit R&D
|
DH101
|
(10-Kit) 14,15-DHET Hypertension ELISA Kit
|
|
Detroit R&D
|
DH2
|
(1-Kit) 14,15-EET/DHET Hypertension ELISA Kit
|
|
Detroit R&D
|
DH12
|
(2-Kit) 14,15-EET/DHET Hypertension ELISA Kit
|
|
Detroit R&D
|
DH22
|
(5-Kit) 14,15-EET/DHET Hypertension ELISA Kit
|
|
Detroit R&D
|
DH102
|
(10-Kit) 14,15-EET/DHET Hypertension ELISA Kit
|
|
Detroit R&D
|
DH3
|
(1-Kit) 14,15-DHET Human Urine ELISA Kit
|
|
Detroit R&D
|
DH13
|
(2-Kit) 14,15-DHET Human Urine ELISA Kit
|
|
Detroit R&D
|
DH23
|
(5-Kit) 14,15-DHET Hman Urine ELISA Kit
|
|
Detroit R&D
|
DH103
|
(10-Kit) 14,15-DHET Human Urine ELISA Kit
|
|
Detroit R&D
|
DH4
|
(1-Kit) 11,12-DHET Immunoassay Kit
|
|
Detroit R&D
|
DH14
|
(2-Kit) 11,12-DHET Immunoassay Kit
|
|
Detroit R&D
|
DH24
|
(5-Kit) 11,12-DHET Immunoassay Kit
|
|
Detroit R&D
|
DH104
|
(10-Kit) 11,12-DHET Immunoassay Kit
|
|
Detroit R&D
|
DH5
|
(1-Kit )11,12-EET/DHET Immunoassay Kit
|
|
Detroit R&D
|
DH15
|
(2-Kit) 11,12-EET/DHET Immunoassay Kit
|
|
Detroit R&D
|
DH25
|
(5-Kit) 11,12-EET/DHET Immunoassay Kit
|
|
Detroit R&D
|
DH105
|
(10-Kit) 11,12-EET/DHET Immunoassay Kit
|
|
Detroit R&D
|
SH1
|
(1-Kit) 14,15-DHET sEH activity ELISA Kit
|
|
Detroit R&D
|
SH11
|
(2-Kit) 14,15-DHET sEH activity ELISA Kit
|
|
Detroit R&D
|
SH21
|
(5-Kit) 14,15-DHET sEH activity ELISA Kit
|
|
Detroit R&D
|
SH101
|
(10-Kit) 14,15-DHETsEH activity ELISA Kit
|
|
Detroit R&D
|
20H1
|
(1-Kit) 20-HETE Hypertension ELISA Kit
|
|
Detroit R&D
|
20H11
|
(2-Kit) 20-HETE Hypertension ELISA Kit
|
|
Detroit R&D
|
20H21
|
(5-Kit) 20-HETE Hypertension ELISA Kit
|
|
Detroit R&D
|
20H101
|
(10-Kit) 20-HETE Hypertension ELISA Kit
|
|
Detroit R&D
|
20HG1
|
(1-Kit) 20-HETE/b-glucuronidase Hypertension ELISA Kit
|
|
Detroit R&D
|
20HG11
|
(2-Kit) 20-HETE/b-glucuronidase Hypertension ELISA Kit
|
|
Detroit R&D
|
20HG21
|
(5-Kit) 20-HETE/b-glucuronidase Hypertension ELISA Kit
|
|
Detroit R&D
|
20HG101
|
(10-Kit) 20-HETE/b-glucuronidase Hypertension ELISA Kit
|
|
Detroit R&D
|
8iso1
|
(1-Kit) 8-isoprostane oxidative stress ELISA Kit
|
|
Detroit R&D
|
8iso11
|
(2-Kit) 8-isoprostane oxidative stress ELISA Kit
|
|
Detroit R&D
|
8iso21
|
(5-Kit) 8-isoprostane oxidative stress ELISA Kit
|
|
Detroit R&D
|
8iso101
|
(10-Kit) 8-isoprostane oxidative stress ELISA Kit
|
|
Detroit R&D
|
8isoU1
|
(1-Kit) Urinary 8-isoprostane oxidative stress ELISA Kit
|
|
Detroit R&D
|
8isoU11
|
(2-Kit) Urinary 8-isoprostane oxidative stress ELISA Kit
|
|
Detroit R&D
|
8isoU21
|
(5-Kit) Urinary 8-isoprostane oxidative stress ELISA Kit
|
|
Detroit R&D
|
8isoU101
|
(10-Kit) Urinary 8-isoprostane oxidative stress ELISA Kit
|
|
Detroit R&D
|
BPA 1
|
(1-Kit) BPA Environmental Estrogen ELISA Kit
|
|
Detroit R&D
|
BPA 11
|
(2-Kit) BPA Environmental Estrogen ELISA Kit
|
|
Detroit R&D
|
BPA 21
|
(5-Kit) BPA Environmental Estrogen ELISA Kit
|
|
Detroit R&D
|
BPA 101
|
(10-Kit) BPA Environmental Estrogen ELISA Kit
|
|
Detroit R&D
|
NG1
|
(1-Kit) NAG-1, MIC-1, GDF-15 Prostate Cancer ELISA Kit
|
|
Detroit R&D
|
NG11
|
(2-Kit) NAG-1, MIC-1, GDF-15 Prostate Cancer ELISA Kit
|
|
Detroit R&D
|
NG21
|
(5-Kit) NAG-1, MIC-1, GDF-15 Prostate Cancer ELISA Kit
|
|
Detroit R&D
|
NG101
|
(10-Kit) NAG-1, MIC-1, GDF-15 Prostate Cancer ELISA Kit
|
|
Detroit R&D
|
PA1
|
(1-Kit) PSA Cancer ELISA Kit
|
|
Detroit R&D
|
PA21
|
(5-Kit) PSA Cancer ELISA Kit
|
|
Detroit R&D
|
PA101
|
(10-Kit) PSA Cancer ELISA Kit
|
